Showing results (51-60 of 88) with videos related to
Sort By:
Pageof 9
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 29, 2024
Knowledge and competences in hematological malignancies amongst radiation oncology residents in Germany-results from a national surveyStephan Rehn, Michael Oertel, Philipp Linde, et al.Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 30, 2020
Radiation treatment of hemato-oncological patients in times of the COVID-19 pandemic : Expert recommendations from the radiation oncology panels of the German Hodgkin Study Group and the German Lymphoma AllianceM Oertel, K Elsayad, R Engenhart-Cabillic, et al.Plos One|February 22, 2020
Radiation synergizes with antitumor activity of CD13-targeted tissue factor in a HT1080 xenograft model of human soft tissue sarcomaCaroline Brand, Burkhard Greve, Tobias Bölling, et al.Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|June 1, 2021
Analysis of extracorporeal photopheresis within the frame of the WAA registerM Blaha, Z Gasova, G Berlin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 11, 2009
Hodgkin's lymphoma in adolescents treated with adult protocols: a report from the German Hodgkin study groupDennis A Eichenauer, Henning Bredenfeld, Heinz Haverkamp, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2006
Poorer outcome of elderly patients treated with extended-field radiotherapy compared with involved-field radiotherapy after chemotherapy for Hodgkin's lymphoma: an analysis from the German Hodgkin Study GroupB Klimm, H T Eich, H Haverkamp, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 12, 2005
Extended field radiotherapy, combined modality treatment or involved field radiotherapy for patients with stage IA lymphocyte-predominant Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Study Group (GHSG)L Nogová, T Reineke, H T Eich, et al.Nuklearmedizin. Nuclear Medicine|September 22, 2015
Concordance in the interpretation of PET after chemotherapy in advanced stage Hodgkin lymphomaC Kobe, G Kuhnert, H Haverkamp, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 7, 2012
Comparing long-term toxicity and efficacy of combined modality treatment including extended- or involved-field radiotherapy in early-stage Hodgkin's lymphomaS Sasse, B Klimm, H Görgen, et al.Cancers|December 23, 2023
Impact of Modern Low Dose Involved Site Radiation Therapy on Normal Tissue Toxicity in Cervicothoracic Non-Hodgkin Lymphomas: A Biophysical StudyJulian Roers, Daniel Rolf, Andrea Baehr, et al.Pageof 9